Retirement Planning Group (Kansas)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$271K Sell
2,143
-3,164
-60% -$417K 0.01% 457
2026
Q1
$740K Buy
5,307
+81
+2% +$11.3K 0.02% 237
2025
Q4
$641K Buy
+5,226
New +$635K 0.02% 235
2015
Q3
Sell
-2,100
Closed -$246K 57
2015
Q2
$246K Sell
2,100
-900
-30% -$98.3K 0.1% 52
2015
Q1
$294K Buy
+3,000
New +$305K 0.12% 53

Other funds holding GILD

Retirement Planning Group (Kansas)'s GILD Position: Q2 2026 in Review

Retirement Planning Group (Kansas) reduced its Gilead Sciences (GILD) stake by 60% in Q2 2026, selling an estimated $417K and leaving 2,143 shares worth $271K. The position accounts for 0.01% of the portfolio, ranked #457.

Retirement Planning Group (Kansas) first reported a position in GILD in Q1 2015 and has held it in 5 quarters since. The position peaked at $740K in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Retirement Planning Group (Kansas) held 2,143 shares of Gilead Sciences worth $271K as of Q2 2026.
  • Retirement Planning Group (Kansas) sold 3,164 Gilead Sciences shares in Q2 2026, an estimated $417K.
  • Gilead Sciences made up 0.01% of Retirement Planning Group (Kansas)'s portfolio in Q2 2026, its #457 holding.
  • Retirement Planning Group (Kansas) first reported a position in Gilead Sciences in Q1 2015 and has held it in 5 quarters since.
  • Retirement Planning Group (Kansas)'s Gilead Sciences position peaked at $740K in Q1 2026.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Retirement Planning Group (Kansas)'s 13F filing for Q2 2026, filed 5 Aug 2026.